Censa Pharmaceuticals Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$544M
Censa Pharmaceuticals General Information
Description
Developer of bio-medical therapeutics designed to treat (ultra) orphan CNS disorders. The company's therapeutics treat orphan metabolic diseases with earlier stage programs targeting central nervous system diseases, disorders of neurotransmitter degradation and synthesis, enabling patients to recover debilitating diseases.
Contact Information
Website
www.censapharma.comCorporate Office
- 65 William Street
- Suite 200
- Wellesley, MA 02481
- United States
Corporate Office
- 65 William Street
- Suite 200
- Wellesley, MA 02481
- United States
Censa Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 29-May-2020 | $544M | Completed | Clinical Trials - Phase 3 | ||
| 3. Merger/Acquisition | 05-Jan-2018 | Cancelled | Startup | |||
| 2. Early Stage VC (Series A2) | 21-Nov-2017 | $1.5M | $3.01M | Completed | Startup | |
| 1. Early Stage VC (Series A1) | 19-Apr-2016 | $1.51M | $1.51M | Completed | Startup |
Censa Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 |
Censa Pharmaceuticals Comparisons
Industry
Financing
Details
Censa Pharmaceuticals Competitors (2)
One of Censa Pharmaceuticals’s 2 competitors is BioMarin Pharmaceutical, a Formerly PE-Backed company based in San Rafael, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioMarin Pharmaceutical | Formerly PE-Backed | San Rafael, CA | ||||
| Synlogic | Formerly VC-backed | Winchester, MA |
Censa Pharmaceuticals Signals
Censa Pharmaceuticals Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Arkin Capital | Asset Manager | Minority | ||
| InClin Investments | Angel Group | Minority |
Censa Pharmaceuticals FAQs
-
When was Censa Pharmaceuticals founded?
Censa Pharmaceuticals was founded in 2015.
-
Where is Censa Pharmaceuticals headquartered?
Censa Pharmaceuticals is headquartered in Wellesley, MA.
-
What is the size of Censa Pharmaceuticals?
Censa Pharmaceuticals has 7 total employees.
-
What industry is Censa Pharmaceuticals in?
Censa Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Censa Pharmaceuticals a private or public company?
Censa Pharmaceuticals is a Private company.
-
What is the current valuation of Censa Pharmaceuticals?
The current valuation of Censa Pharmaceuticals is .
-
What is Censa Pharmaceuticals’s current revenue?
The current revenue for Censa Pharmaceuticals is .
-
How much funding has Censa Pharmaceuticals raised over time?
Censa Pharmaceuticals has raised $3.01M.
-
Who are Censa Pharmaceuticals’s investors?
Arkin Capital and InClin Investments have invested in Censa Pharmaceuticals.
-
Who are Censa Pharmaceuticals’s competitors?
BioMarin Pharmaceutical and Synlogic are competitors of Censa Pharmaceuticals.
-
When was Censa Pharmaceuticals acquired?
Censa Pharmaceuticals was acquired on 29-May-2020.
-
Who acquired Censa Pharmaceuticals?
Censa Pharmaceuticals was acquired by PTC Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process